Nightingale Health Oyj Class B HEALTH
OMXHEX · Finland · Commercial Services
€1.22+0.29 (+31.75%)
Market closed· · EUR · Data may be delayed
Prices may be delayed and are for informational purposes only - not investment advice.
Market closed· · EUR · Data may be delayed
Prices may be delayed and are for informational purposes only - not investment advice.
Total return, dividends included.
Where the price sits against its 50- and 200-day moving averages.
Makkler Fair Value, financial health score, analyst view, peers and MakklerAI.
Genom will make the test available to its healthcare network while Nightingale Health will analyse the blood samples.
The European market has shown resilience, with the STOXX Europe 600 Index seeing modest gains amid ongoing geopolitical developments and economic adjustments. Despite the complexities of current global conditions, investors are increasingly interested in exploring opportunities within smaller or newer companies. Penny stocks, though an older term, continue to represent a viable investment area by highlighting these less-established entities that can offer significant potential when backed by...
The pan-European STOXX Europe 600 Index recently reached a new intraday high, reflecting optimism about the eurozone economy despite ongoing market volatility. For investors seeking opportunities beyond well-known names, penny stocks—often representing smaller or newer companies—can offer intriguing prospects. Although the term "penny stocks" might seem outdated, these investments remain relevant as they can provide growth potential at lower price points when backed by strong financials and...
Recent third-party headlines about this company, kept separate from Makkler's own editorial coverage and linking out to the publisher. Accuracy is the publisher's responsibility.